The quip points at muscle loss during GLP-1 weight loss. Frigon says patients are told to add milk protein to help hold on to muscle.
Recap by typeshit. Post by Ronald K. OBrien II on X.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Novo, Lilly and Zealand showed amylin trial data in Milan. CagriSema hit 22.4% average weight loss in a trial and has an FDA decision expected by year end.
Walmart is widening free prescriptions for staff while other big employers scale back drug benefits. The snippet doesn't say if GLP-1s are covered.
Loading…